Two drugs for mums better than one
Giving pregnant HIV positive women two anti-AIDS drugs rather than one substantially reduces the chances of them passing the virus on to their babies, delegates to the 14th world AIDS conference in Barcelona were told yesterday (Monday).
According to Dr Mary Glenn Fowler of the US Centres for Disease Control, a study from Thailand showed that a combination of the drugs AZT and nevirapine for mothers and AZT for babies reduced the HIV transmission rate to 3,9%.
Nevirapine alone, which is what is used in South Africa, cuts the transmission rate by up to 50%.
Fowler said that a short course of anti-AIDS drugs for mothers during pregnancy should also be considered as it reduced their viral loads, making it less likely that they would pass HIV to their babies.
Meanwhile research due to be presented on Thursday by South Africa’s Dr Glenda Gray shows that giving nevirapine to babies only shortly after birth was as effective in blocking HIV transmission as treating both mothers and babies.
HIV transmission via breastfeeding continues to pose a danger for babies, said Fowler, but it was generally accepted that it was more dangerous for babies in areas without clean running water to be formula fed. However, researchers and governments needed to find ways to support HIV positive women who chose not to breastfeed, such as manufacturing cheap pre-mixed long-life formula milk.
Meanwhile, the World Health Organisation’s (WHO) Isabelle de Zoysa said her organisation had serious reservations about universally dishing out nevirapine to pregnant women who had not had HIV tests in areas where HIV infection was high.
Women at some of the nevirapine sites in South Africa have asked to be given the drug but not the test as they were too afraid to know their HIV status.
However, De Zoysa said this was not ideal as the voluntary counselling and HIV testing that were the cornerstone of most prevention of mother-to-child transmission programmes enabled women who tested HIV positive to get access to support and care and were educated about the risk posed by breastfeeding.
Author
-
Kerry Cullinan is the Managing Editor at Health-e News Service. Follow her on Twitter @kerrycullinan11
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Two drugs for mums better than one
by Kerry Cullinan, Health-e News
July 9, 2002
Related
MSF: Secret medicine prices cost lives
Doctors Without Borders (MSF) is calling upon governments to put an end to the secrecy that rules in the field of pharmaceutical products when they meet this week at the World Health Organisation Fair Pricing Forum to discuss access to essential medicines.
Still many pitfalls, but impressive progress
Sandile died a few weeks ago. Although he was on antiretroviral medication for HIV, he had started treatment late and his body could not rally the energy to fight the tuberculosis that preyed on his weak immune system.